Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon International Regulatory News (PIN)

Share Price Information for Pantheon International (PIN)

Share Price is delayed by 15 minutes
Get Live Data
390.00    -2.50 (-0.64%)
Bid:
390.00
Ask:
392.00
Spread: 2.00 (0.513%)
Market Cap: £1.59b
PIN Live PriceLast checked at - London Stock Exchange

Intraday Pantheon International Share Chart

Monthly Performance Update

19 Feb 2016 07:00

RNS Number : 4934P
Pantheon International PLC
19 February 2016
 

19th February 2016

 

Pantheon International Plc

Performance Update at 31st January 2016

 

 

Month to 31st January 2016

 

Pantheon International Plc ("PIP") announces an unaudited net asset value ("NAV") per share at 31st January 2016 of 1,720.2p, an increase of 62.7p (3.8%) from the NAV per share as at 31st December 2015. Valuation gains (2.7p, 0.2%), investment income (1.3p, 0.1%) and foreign exchange gains (61.0p, 3.7%) were offset by expenses and taxes* (-2.3p, -0.2%).

PIP's valuation policy for private equity funds is based on the latest valuations reported by the managers of the funds in which PIP has holdings. In the case of PIP's valuation at 31st January 2016, the majority of reported valuations (accounting for circa 95% by value) are dated 30th September 2015 or later.

 

 

At 31st January 2016, PIP's private equity assets stood at £941m, whilst cash balances were £180m. Undrawn commitments to investments stood at £308m at 31st January 2016, calculated using exchange rates at that date. In addition, the Company's multi-currency revolving credit facility agreement, comprising a US$100m facility and a €46m facility, remained completely undrawn.

 

PIP's portfolio generated net cash of £10.5m during the month, with distributions of £16.1m relative to £5.6m of calls from existing commitments to private equity funds.

 

Investments completed during the month include a £14.2m secondary commitment to an Asian growth equity fund that was 80% funded at completion and a £9.1m primary commitment to CHAMP IV, an Australian mid-market buyout fund. 

 

 

 

* Withholding taxes on investment distributions.

Monthly Report

The January monthly newsletter can be accessed on PIP's website at www.piplc.com in the Investor Relations section under the heading "Newsletters", or by following this link: http://www.piplc.com/investor-relations/newsletters.

 

 

Ends  

NOTES

PIP

PIP is a London quoted investment trust, managed by Pantheon Ventures (UK) LLP ("Pantheon"), a leading global private equity fund investor, investing in both primary funds and secondary transactions, and from time to time capitalising further on its fund investment activities by acquiring direct holdings in unquoted companies, usually either where a vendor is seeking to sell a combined portfolio of fund interests and direct holdings or where there is a private equity manager, well known to Pantheon, investing on substantially the same terms. With investments in private equity funds, covering multiple private equity strategies ranging from investments in late stage buyouts to early stage technology, PIP enables individuals as well as institutions to gain access to a substantial portfolio of unquoted companies in the USA, the UK, Continental Europe and Asia, within funds managed by experienced private equity managers.

 

Pantheon

Pantheon is a leading global private equity fund investor that invests on behalf of over 380 institutional investors. Established over 30 years ago, Pantheon has developed a strong reputation and track record in primary, secondary and co-investments and across all stages and geographies. Pantheon has £21.4 billion in AUM** (as at 30th September 2015), 200 employees, including 70 investment professionals, located across offices in London, San Francisco, New York, Hong Kong, Seoul and Bogotá.

 

** This figure includes assets subject to discretionary or non-discretionary management, advice or those limited to a reporting function.

 

For more information please visit PIP's website at www.piplc.com or contact:

 

Andrew Lebus or Vicki Bradley

Pantheon

020 3356 1800

 

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of this announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFDFEAFMSEIE
Date   Source Headline
18th Oct 20238:18 amRNSResult of Tender Offer
28th Sep 202312:06 pmRNSInvestor Presentation
25th Sep 20237:00 amRNSTender Offer
22nd Sep 20237:00 amRNSMonthly Performance Update
19th Sep 202312:41 pmRNSHolding(s) in Company
1st Sep 202312:16 pmRNSTotal Voting Rights
1st Sep 20237:00 amRNSTransaction in Own Shares
25th Aug 20237:00 amRNSMonthly Performance Update
24th Aug 20237:00 amRNSTransaction in Own Shares
23rd Aug 20237:00 amRNSTransaction in Own Shares
22nd Aug 20237:00 amRNSTransaction in Own Shares
14th Aug 20237:00 amRNSTransaction in Own Shares
11th Aug 20234:00 pmRNSQuotedData's Weekly News & Interview
11th Aug 20237:00 amRNSTransaction in Own Shares
10th Aug 20235:22 pmRNSDirector/PDMR Shareholding
10th Aug 20237:00 amRNSTransaction in Own Shares
9th Aug 202310:51 amRNSDirector/PDMR Shareholding
8th Aug 20232:54 pmRNSDirector/PDMR Shareholding
8th Aug 202311:59 amRNSDirector/PDMR Shareholding
8th Aug 20237:00 amRNSTransaction in Own Shares
7th Aug 20235:24 pmRNSDirector/PDMR Shareholding
4th Aug 20235:22 pmRNSTransaction in Own Shares
4th Aug 20234:32 pmRNSDirector/PDMR Shareholding
4th Aug 20232:36 pmRNSDirector/PDMR Shareholding
3rd Aug 20234:37 pmRNSTransaction in Own Shares
3rd Aug 20233:44 pmRNSNotice of AGM
3rd Aug 202311:45 amRNSShare Buyback Programme
3rd Aug 20237:00 amRNSAnnual Financial Report
31st Jul 202312:54 pmRNSAppointment of Joint Corporate Broker
25th Jul 20232:11 pmRNSAppointment of Non-Executive Director
21st Jul 202310:32 amRNSCorrection – Monthly Performance Update
21st Jul 20237:00 amRNSMonthly Performance Update
11th Jul 202311:54 amRNSHolding(s) in Company
6th Jul 20237:00 amRNSMonthly Performance Update
5th Jul 202312:08 pmRNSAppointment of Non-Executive Director
30th Jun 202311:32 amRNSAppointment of Co-lead Portfolio Manager
21st Jun 20234:55 pmRNSHolding(s) in Company
31st May 20235:08 pmRNSHolding(s) in Company
19th May 20237:00 amRNSMonthly Performance Update
5th May 20236:05 pmRNSDirector/PDMR Shareholding
2nd May 202312:07 pmRNSTotal Voting Rights
21st Apr 20237:00 amRNSMonthly Performance Update
5th Apr 20235:15 pmRNSTransaction in Own Shares
3rd Apr 20235:58 pmRNSHolding(s) in Company
3rd Apr 202310:26 amRNSTotal Voting Rights
31st Mar 20235:45 pmRNSTransaction in Own Shares
30th Mar 20235:52 pmRNSTransaction in Own Shares
24th Mar 20237:00 amRNSMonthly Performance Update
17th Mar 202310:00 amEQSHardman & Co Research on Q&A on Pantheon International (PIN): Long-term out-performance from exceptional companies
13th Mar 20233:24 pmRNSStatement on Silicon Valley Bank (SVB)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.